Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enovis (ENOV) Research & Development (2021 - 2025)

Enovis (ENOV) has disclosed Research & Development for 7 consecutive years, with $31.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 30.95% to $31.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $120.3 million, a 31.8% increase, with the full-year FY2025 number at $120.3 million, up 31.8% from a year prior.
  • Research & Development was $31.4 million for Q4 2025 at Enovis, up from $29.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $31.4 million in Q4 2025 to a low of $11.0 million in Q3 2021.
  • A 5-year average of $20.6 million and a median of $19.4 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: rose 2.96% in 2024, then soared 45.13% in 2025.
  • Enovis' Research & Development stood at $12.5 million in 2021, then rose by 18.2% to $14.7 million in 2022, then increased by 24.41% to $18.3 million in 2023, then surged by 30.74% to $24.0 million in 2024, then soared by 30.95% to $31.4 million in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Research & Development are $31.4 million (Q4 2025), $29.7 million (Q4 2025), and $30.7 million (Q3 2025).